Rebalancing gut microbiome lengthens survival in mouse model of ALS

Medical Xpress discusses how researchers using a mouse model of ALS have found ways to help correct gut microbiome imbalance symptoms, which stem from ALS:

"A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS - a progressive, neurodegenerative disease.

Researchers at the University of Illinois at Chicago College of Medicine report that in a mouse model of ALS, the compound butyrate helped correct a gut microbiome imbalance and reduced gut leakiness - both symptoms of ALS. The treated mice lived also longer compared to mice that weren't given butyrate."

Read the complete article at: